Patients Deserve More Say About the Coverage of Lifesaving Medications
There is a war going on right now pitting thousands of ailing patients and their doctors against people in board rooms in an effort to win the right to access lifesaving…
What is ICER and Why Does it Matter?
What is the Institute for Clinical and Economic Review, and why does ICER matter? I received this exact question from a patient recently. After all, the Institute for Clinical and…
Charity Calls on Nice to Reverse Opdivo Rejection
Kidney Cancer UK is calling on the National Institute for Health and Care Excellence to reverse a preliminary decision to bar patients with kidney cancer from NHS access to the…
Icer’s Multiple Myeloma Report: The Final Take
By: Terry Wilcox | Patients Rising The final ICER Multiple Myeloma report was released on June 9th and came in at breezy 185-pages. Because we know you have a life, we're giving…
Allowing ICER into Medicare Does Not Achieve Value
As the foundation of the healthcare policy landscape undergoes a tectonic shift that promises to reward “value” in care rather than “volume” of services, stakeholders of all types have cautiously…
An Interview with Donna Cryer, Global Liver Institute, on Assessing The Value of Treatments for Liver Disease
Donna Cryer, JD, a liver transplant recipient and founder, president and CEO of the Global Liver Institute, is a passionate advocate for patients. She is a familiar presence at health care…
As Heart Disease Plagues the Black Community, America’s Access to Medicines May Be Headed for Crisis
Heart disease is the longstanding No. 1 killer of Americans, and the leading cause of death among Marylanders. While this silent killer devastates populations of all racial and ethnic groups,…
Stop Insurers From Putting Profits Ahead of Health
Blaming pharmaceutical companies for high drug prices should be a bipartisan affair. If lawmakers want to hold the responsible culprits accountable, they need to look at all sectors of the…
Cutting ‘My’ Patients Out of the Health Care Economics Equation
Health insurers searching to lower costs and maximize profits have begun to limit patients’ access to innovative drugs. Most physicians, however, realize that this is a terrible idea. Patient health…
Healthcare’s War on Costs is Really a War on Patients
ICER and cost control guru Peter Bach are slamming the brakes on innovation No matter what side of the aisle you’re on, we can all agree that medical progress should…